CAN 33.3% 6.0¢ cann group limited

Ann: S3 Trial update, page-18

  1. 106 Posts.
    lightbulb Created with Sketch. 12
    Confirms what everyone already knew and certainly the TGA knew, CBD at that dosage has no therapuetic effect.

    That is why a S3 was allowed in the first place.

    Poor shareholders led up a garden path, only flowers left and that can be done in a $10m facility.
 
watchlist Created with Sketch. Add CAN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.